1. Sweden Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
Gasporox AB

Gasporox AB

SSTO:GPX
5.50
SEK
-1.45
(-20.86%)
-0.97EPS
69.03MMarket Cap
Oct 22Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.26
0.65
1.1
1.15
1.65
1.62
1.83
2.49
3.65
3.88
3.38
3.31
Basic EPS, GAAP
- -
-0.75
-1.09
-1.12
-1.16
-0.9
-0.57
-0.63
-0.51
-0.14
-0.3
-0.82
-0.97
Free Cash Flow per Basic Share
- -
-1.62
-1.57
-1.23
-1.97
-0.99
-0.79
-1.15
-0.96
-0.46
-0.4
-1.34
0.37
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.09
0.92
3.57
2.93
3.68
4.25
3.96
3.33
2.84
2.7
2.85
2.12
1.95
Tangible Book Value per Share
-0.87
-0.15
2.61
1.35
2.06
2.92
2.77
1.74
0.88
0.45
0.53
-0.3
-0.48
Basic Weighted Avg Shares
5
5
3
5
5
6
8
9
9
9
9
9
9
Sales/Revenue/Turnover
- -
1
2
5
6
10
12
16
21
31
34
32
31
Operating Margin (%)
- -
-278.52
-168.77
-107.02
-105.39
-54.77
-35.02
-34.25
-23.18
-4.2
-8.59
-21.64
-23.64
Depreciation Expense
- -
1
1
2
2
2
3
3
3
4
5
6
6
Net Income, GAAP
- -
-4
-4
-5
-6
-6
-4
-5
-4
-1
-3
-8
-9
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-289.05
-168.14
-102.05
-100.57
-54.82
-35.03
-34.25
-20.48
-3.96
-7.85
-24.42
-29.22
Working Capital
-4
-1
12
7
17
15
24
15
16
5
6
11
9
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
15
- -
Total Equity
- -
4
17
14
27
30
34
29
24
23
27
20
18
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-148.44
-35.69
-33.64
-34.43
-22.78
-14.4
-17.2
-16.55
-5.23
-10.73
-33.13
-40.22

Capital Structure

SEK

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
ST Debt
- -
1
- -
LT Borrowings
- -
15
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
69
70
69

Working Capital

SEK

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
Total Current Assets
27
26
23
Cash, Cash Equivalents & STI
12
7
13
Accounts Receivable, Net
- -
12
- -
Inventories
7
6
5
Total Current Liabilities
18
16
14
Payables & Accruals
- -
- -
- -
ST Debt
- -
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.85%
-9.24%
-25.58%
Free Cash Flow
26.12%
47.69%
255.77%
Net Income, GAAP
26.96%
47.27%
188.15%
Sales/Revenue/Turnover
42.89%
22.06%
-7.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9
10
8
8
34
2025
4
7
- -
11
32
2026
9
- -
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
-0.17
-0.12
-0.3
2025
-0.49
-0.41
- -
0.11
-0.82
2026
-0.17
- -
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Märta Lewander Xu
Full Time Employees
22
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Tellusgatan 13 Lund SN Sweden 224 57
IPO Date
Oct 25, 2016
Website
gasporox.se
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
Gasporox AB (publ) (GPX.ST) develops and commercializes tunable diode laser absorption spectroscopy (TDLAS) technology, specializing in Gas in Scattering Media Absorption Spectroscopy (GASMAS) for non-destructive, non-intrusive headspace gas analysis and leak detection in pharmaceutical, food, and beverage packaging; the company offers benchtop instruments including the GPX1500 Vial for oxygen inspection in vials and ampoules, GPX1500 Film Pharma for intravenous bags and pouches, and GPX1500 Film Food for flexible food packaging; sensor modules such as VialArch for in-line integration on production lines, GasSpect series (O2, H2O, CO2, CO2 & Bar, Flex) for various headspace gases, CellSpect CO2 for leak testing, GPX Porosity for pharmaceutical substrates, and AutoMAP for modified atmosphere packaging; it also provides customized measurement services, calibration, training, IQ/OQ protocols, and integration support. Founded in 2005 and headquartered in Lund, Sweden, Gasporox operates globally with approximately 20 employees, targeting quality control, manufacturing, and R&D in pharma, food, and beverage sectors. Recent developments include the launch of BottleArch in early 2025 for non-intrusive testing of large-volume parenterals at up to 600 units per minute, a SEK 15.4 million strategic investment from Gobia Enterprises in January 2025 to fund pharmaceutical market expansion and technology development, a SEK 4.4 million order for VialArch from Maxcann in December 2025, and the upcoming debut of the plug-and-play LineArch in-line CCIT/HSA system at CPHI 2025 in Frankfurt.